Salesforce’s (CRM) “Overweight” Rating Reiterated at Cantor Fitzgerald
Cantor Fitzgerald reaffirmed their overweight rating on shares of Salesforce (NYSE:CRM – Free Report) in a report published on Thursday,Benzinga reports. They currently have a $250.00 target price on the CRM provider’s stock. Several other research analysts have also recently weighed in on CRM. Daiwa Securities Group lowered their price target on shares of Salesforce […]
Mercury Systems’ (MRCY) Overweight Rating Reiterated at Piper Sandler
Piper Sandler restated their overweight rating on shares of Mercury Systems (NASDAQ:MRCY – Free Report) in a research note issued to investors on Wednesday, MarketBeat reports. The firm currently has a $131.00 price target on the technology company’s stock, up from their prior price target of $126.00. MRCY has been the topic of a number […]
Quince Therapeutics’ (QNCX) “Overweight” Rating Reiterated at Cantor Fitzgerald
Cantor Fitzgerald reissued their overweight rating on shares of Quince Therapeutics (NASDAQ:QNCX – Free Report) in a research report sent to investors on Tuesday, Marketbeat.com reports. Cantor Fitzgerald currently has a $70.00 price target on the stock. Other equities research analysts also recently issued reports about the stock. Zacks Research raised shares of Quince Therapeutics […]
MiMedx Group’s (MDXG) “Overweight” Rating Reiterated at Cantor Fitzgerald
Cantor Fitzgerald reissued their overweight rating on shares of MiMedx Group (NASDAQ:MDXG – Free Report) in a report issued on Monday morning, Marketbeat Ratings reports. Cantor Fitzgerald currently has a $8.00 price target on the stock. Several other analysts have also weighed in on MDXG. Wall Street Zen lowered MiMedx Group from a “hold” rating […]
Watsco’s (WSO) “Overweight” Rating Reiterated at Stephens
Watsco (NYSE:WSO – Get Free Report)‘s stock had its “overweight” rating restated by analysts at Stephens in a report issued on Monday,Benzinga reports. They currently have a $485.00 price target on the construction company’s stock. Stephens’ target price suggests a potential upside of 55.13% from the stock’s current price. A number of other equities research […]
last updated on 30 Aug 09:49